SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-18-000071
Filing Date
2018-11-06
Accepted
2018-11-06 17:25:14
Documents
100
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bauschhealthcompaniesincq3.htm 10-Q 2833172
2 EXHIBIT 31.1 exhibit311q32018.htm EX-31.1 14314
3 EXHIBIT 31.2 exhibit312q32018.htm EX-31.2 14349
4 EXHIBIT 32.1 exhibit321q32018.htm EX-32.1 8626
5 EXHIBIT 32.2 exhibit322q32018.htm EX-32.2 8615
  Complete submission text file 0000885590-18-000071.txt   13178155

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bhc-20180930.xml EX-101.INS 3184874
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20180930.xsd EX-101.SCH 85457
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20180930_cal.xml EX-101.CAL 126073
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20180930_def.xml EX-101.DEF 448920
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20180930_lab.xml EX-101.LAB 968086
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20180930_pre.xml EX-101.PRE 603659
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 181164014
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1